StockData
Natera, Inc. logo

Natera, Inc.

NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 10/30234% above fair value
$378.92−35.38 (-8.54%)

Close on Nov 2, 2026Market cap $54.62BP/E –Yield –

Natera Unvested RSUs Weighted-Average Grant-Date Fair Value by Year

Unvested RSUs Weighted-Average Grant-Date Fair Value ($/sh) ($)

Natera Unvested RSUs Weighted-Average Grant-Date Fair Value: $100 in FY2025, up 63.9% from a year earlier. That is the highest of the 9 years on record here.

Latest, FY2025
100
Period ended Dec 31, 2025
Change on a year earlier
+63.9%
61.28 in FY2024
History
9 years
Since FY2017
Sources
9
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-Q (2026-08-07) ↗

Reported in Form 10-K/10-Q Note — Stock-Based Compensation (XBRL).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedUnvested RSUs Weighted-Average Grant-Date Fair Value ($/sh) ($)Year on yearSource
FY2025Dec 31, 2025100+63.9%Form 10-Q (2026-08-07) ↗
FY2024Dec 31, 202461.28+23.8%Form 10-K (2026-02-27) ↗
FY2023Dec 31, 202349.50-13.3%Form 10-K (2025-02-28) ↗
FY2022Dec 31, 202257.12-23.2%Form 10-K (2024-02-29) ↗
FY2021Dec 31, 202174.33+118.5%Form 10-K (2023-03-01) ↗
FY2020Dec 31, 202034.02+71.3%Form 10-K (2022-02-25) ↗
FY2019Dec 31, 201919.86+69.5%Form 10-K (2021-02-26) ↗
FY2018Dec 31, 201811.72+12.9%Form 10-K (2020-03-02) ↗
FY2017Dec 31, 201710.38–Form 10-K (2019-03-15) ↗

Cite this data

StockData. (2026). Natera Unvested RSUs Weighted-Average Grant-Date Fair Value ($), annual FY2017–FY2025 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/equity-rsu-unvested-wagdfv

See every metric in the Natera KPI table. Data updated Nov 2, 2026.